
|Articles|June 11, 2023
Dermatology Pipeline Updates: Plaque Psoriasis, Atopic Dermatitis and More
Author(s)Lauren Biscaldi, MS
Advertisement
The current dermatology pipeline includes a wide range of medication classes, from Janus kinase (JAK) inhibitors to tumor necrosis factor inhibitors, to phototherapeutics. At the 2023 American Society of Health-System Pharmacists (ASHP) Summer Meetings and Exhibition,1 Courtney Queen, PharmD, CSP, of the University of Kentucky Specialty Pharmacy and Infusion Services in Lexington, Kentucky, shared a quick snapshot of some of that pipeline. Although only 4 conditions were covered—chosen due to the high number of agents in the pipeline—Queen noted that “there are so many more [drugs] we could talk about.”
Reference
1. Rim M, Queen C, Huffmyer M. Specialty pharmacy pipeline updates II: Emerging therapies for complex conditions. Presented at: American Society of Health-System Pharmacists Summer Meetings and Exhibition; June 10-14, 2023; Baltimore, MD.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
How Pharmacists Take Control of Medical Billing
2
Pharmacists Essential for Managing Patient Safety in Self-Medication
3
FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol
4
Lowered Pneumococcal Vaccination Age Has Yet to Close Awareness Gap
5






























